Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Post-Cesarean Mechanical Pain Threshold
ChiCTR2300069812Phase 4Not yet recruiting
- Sponsor
- West China Second University Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by West China Second University Hospital. Primary endpoint: Wound hyperalgesia index. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300069812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069812.